A detailed history of Ubs Group Ag transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,036 shares of ONVO stock, worth $855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,036
Previous 14,355 85.82%
Holding current value
$855
Previous $10,000 90.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.43 - $0.76 $5,297 - $9,362
-12,319 Reduced 85.82%
2,036 $1,000
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.35 $564 - $1,015
-752 Reduced 4.98%
14,355 $10,000
Q1 2024

May 13, 2024

BUY
$0.9 - $1.17 $11,251 - $14,627
12,502 Added 479.92%
15,107 $15,000
Q4 2023

Feb 09, 2024

BUY
$1.05 - $1.84 $2,417 - $4,235
2,302 Added 759.74%
2,605 $2,000
Q2 2023

Aug 11, 2023

SELL
$1.64 - $2.24 $692 - $945
-422 Reduced 58.21%
303 $0
Q1 2023

May 12, 2023

SELL
$1.44 - $3.2 $5,006 - $11,126
-3,477 Reduced 82.75%
725 $1,000
Q4 2022

Feb 08, 2023

SELL
$1.41 - $2.17 $2,877 - $4,428
-2,041 Reduced 32.69%
4,202 $5,000
Q3 2022

Nov 10, 2022

BUY
$1.76 - $3.55 $6,131 - $12,368
3,484 Added 126.28%
6,243 $13,000
Q2 2022

Aug 10, 2022

SELL
$1.71 - $3.71 $3,233 - $7,015
-1,891 Reduced 40.67%
2,759 $5,000
Q1 2022

May 16, 2022

SELL
$2.74 - $4.41 $4,183 - $6,734
-1,527 Reduced 24.72%
4,650 $18,000
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.86 $11,271 - $21,300
3,105 Added 101.07%
6,177 $22,000
Q3 2021

Nov 15, 2021

BUY
$6.08 - $8.92 $1,580 - $2,319
260 Added 9.25%
3,072 $21,000
Q2 2021

Aug 13, 2021

BUY
$6.65 - $9.95 $1,629 - $2,437
245 Added 9.54%
2,812 $26,000
Q1 2021

May 12, 2021

SELL
$8.67 - $21.7 $261,912 - $655,535
-30,209 Reduced 92.17%
2,567 $24,000
Q4 2020

Feb 11, 2021

BUY
$7.19 - $17.05 $225,233 - $534,108
31,326 Added 2160.41%
32,776 $403,000
Q3 2020

Nov 12, 2020

BUY
$6.27 - $15.8 $9,091 - $22,910
1,450 New
1,450 $11,000

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $3.66M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.